IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,970,700 | -60.4% | 5,000,000 | -60.0% | 0.03% | -58.1% |
| Q2 2023 | $12,538,375 | -0.1% | 12,500,000 | 0.0% | 0.06% | +1.6% |
| Q1 2023 | $12,551,625 | +54.5% | 12,500,000 | +66.7% | 0.06% | +60.5% |
| Q4 2022 | $8,121,900 | +7.7% | 7,500,000 | 0.0% | 0.04% | +11.8% |
| Q3 2022 | $7,542,000 | -4.7% | 7,500,000 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $7,910,000 | -7.9% | 7,500,000 | 0.0% | 0.03% | +6.2% |
| Q1 2022 | $8,584,000 | +2.6% | 7,500,000 | 0.0% | 0.03% | +3.2% |
| Q4 2021 | $8,370,000 | -6.1% | 7,500,000 | 0.0% | 0.03% | -20.5% |
| Q3 2021 | $8,910,000 | +0.5% | 7,500,000 | 0.0% | 0.04% | -4.9% |
| Q2 2021 | $8,868,000 | +6.7% | 7,500,000 | 0.0% | 0.04% | -8.9% |
| Q1 2021 | $8,314,000 | -0.8% | 7,500,000 | 0.0% | 0.04% | -8.2% |
| Q4 2020 | $8,385,000 | +12.9% | 7,500,000 | 0.0% | 0.05% | +2.1% |
| Q3 2020 | $7,424,000 | – | 7,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 27,432 | $29,048 | 1.97% |
| SHENKMAN CAPITAL MANAGEMENT INC | 16,386,000 | $17,545,909 | 1.09% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,416,000 | $5,828,097 | 0.88% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,000,000 | $12,996,787 | 0.31% |
| CSS LLC/IL | 5,000,000 | $5,411,355 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,491,000 | $24,353,056 | 0.25% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,700,000 | $24,473,438 | 0.18% |
| Calamos Advisors LLC | 7,500,000 | $8,121,900 | 0.04% |
| Citadel Advisors | 76,517,000 | $82,494,920 | 0.02% |
| AVIVA PLC | 3,000,000 | $3,204,300 | 0.02% |